These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32088230)

  • 1. DNA binding and NIR triggered DNA release from quaternary ammonium modified poly(allylamine hydrochloride) functionalized and folic acid conjugated reduced graphene oxide nanocomposites.
    Roy S; Jaiswal A
    Int J Biol Macromol; 2020 Jun; 153():931-941. PubMed ID: 32088230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(allylamine hydrochloride)-functionalized reduced graphene oxide for synergistic chemo-photothermal therapy.
    Roy S; Sarkar A; Jaiswal A
    Nanomedicine (Lond); 2019 Feb; 14(3):255-274. PubMed ID: 30676277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer.
    Gong T; Wang X; Ma Q; Li J; Li M; Huang Y; Liang W; Su D; Guo R
    J Inorg Biochem; 2021 Oct; 223():111558. PubMed ID: 34329998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release and long-term antibacterial activity of reduced graphene oxide/quaternary ammonium salt nanocomposites prepared by non-covalent modification.
    Ye X; Feng J; Zhang J; Yang X; Liao X; Shi Q; Tan S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():322-329. PubMed ID: 27792981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
    Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced graphene oxide coated Cu
    Zhen SJ; Wang TT; Liu YX; Wu ZL; Zou HY; Huang CZ
    J Photochem Photobiol B; 2018 Mar; 180():9-16. PubMed ID: 29413707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
    Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
    ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.
    Thapa RK; Choi Y; Jeong JH; Youn YS; Choi HG; Yong CS; Kim JO
    Pharm Res; 2016 Nov; 33(11):2815-27. PubMed ID: 27573575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy.
    Liu W; Zhang X; Zhou L; Shang L; Su Z
    J Colloid Interface Sci; 2019 Feb; 536():160-170. PubMed ID: 30366181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydopamine-functionalized nanographene oxide: a versatile nanocarrier for chemotherapy and photothermal therapy.
    Zhang X; Nan X; Shi W; Sun Y; Su H; He Y; Liu X; Zhang Z; Ge D
    Nanotechnology; 2017 Jul; 28(29):295102. PubMed ID: 28656906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-reduced graphene oxide nanocomposites for curcumin delivery: in vitro, in vivo and molecular dynamics simulation study.
    Shi X; Wang Y; Sun H; Chen Y; Zhang X; Xu J; Zhai G
    Biomater Sci; 2019 Feb; 7(3):1011-1027. PubMed ID: 30604794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polydopamine-doped virus-like mesoporous silica coated reduced graphene oxide nanosheets for chemo-photothermal synergetic therapy.
    Liao J; Zhang H; Wang X
    J Biomater Appl; 2020 Jul; 35(1):28-38. PubMed ID: 32279577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The polyvinylpyrrolidone functionalized rGO/Bi2S3 nanocomposite as a near-infrared light-responsive nanovehicle for chemo-photothermal therapy of cancer.
    Dou R; Du Z; Bao T; Dong X; Zheng X; Yu M; Yin W; Dong B; Yan L; Gu Z
    Nanoscale; 2016 Jun; 8(22):11531-42. PubMed ID: 27203525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced synergetic antibacterial activity by a reduce graphene oxide/Ag nanocomposite through the photothermal effect.
    Tan S; Wu X; Xing Y; Lilak S; Wu M; Zhao JX
    Colloids Surf B Biointerfaces; 2020 Jan; 185():110616. PubMed ID: 31740323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological Changes and Cellular Uptake of Functionalized Graphene Oxide Loaded with Protocatechuic Acid and Folic Acid in Hepatocellular Carcinoma Cancer Cell.
    Buskaran K; Hussein MZ; Mohd Moklas MA; Fakurazi S
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy.
    Qiang L; Cai Z; Jiang W; Liu J; Tai Z; Li G; Gong C; Gao S; Gao Y
    J Nanobiotechnology; 2019 Jul; 17(1):83. PubMed ID: 31291948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Anticancer Photothermal Therapy Using the Bystander Effect Enhanced by Antiarrhythmic Peptide Conjugated Dopamine-Modified Reduced Graphene Oxide Nanocomposite.
    Yu J; Lin YH; Yang L; Huang CC; Chen L; Wang WC; Chen GW; Yan J; Sawettanun S; Lin CH
    Adv Healthc Mater; 2017 Jan; 6(2):. PubMed ID: 27860462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide.
    Kim H; Lee D; Kim J; Kim TI; Kim WJ
    ACS Nano; 2013 Aug; 7(8):6735-46. PubMed ID: 23829596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy.
    Qin XC; Guo ZY; Liu ZM; Zhang W; Wan MM; Yang BW
    J Photochem Photobiol B; 2013 Mar; 120():156-62. PubMed ID: 23357205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGO/AuNR/HA-5FU nanocomposite with multi-stage release behavior and efficient antitumor activity for synergistic therapy.
    Yang Y; Wang Y; Zhu M; Chen Y; Xiao Y; Shen Y; Xie A
    Biomater Sci; 2017 May; 5(5):990-1000. PubMed ID: 28300268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.